yk-fh312
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2006 (NCT00511368)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
HIVEP1 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12- Mol. weight
- 584.84 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL404519 ↗
- ChEMBLCHEMBL2218911 ↗
Also known as
- 3-o-(3',3'-dimethylsuccinyl)betulinic acid
- bevirimat
- bevirimat
- bevirimat
- bevirimat
- bevirimat
- bevirimat dimeglumine
- bevirimat dimeglumine
- bevirimat dimeglumine
- dsb*2nmg
- dsb*2nmg
- mpc-4326
- mpc-4326
- mpc-4326
- pa-103001
- pa-103001
- pa103001-01
- pa103001-01
- pa103001-04
- pa103001-04
- pa 457
- pa-457
- pa-457
- pa-457
- pa-457
- pa-457 di-nmg
- pa-457 di-nmg
- pa-457n
- pa-457n
- yk-fh312
- yk-fh312
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01026727 | Phase 2 | Nov 1, 2009 | Myrexis Inc. |
| NCT01097070 | Phase 2 | Nov 1, 2008 | AIDS Research Consortium of Atlanta, Community Research Initiative of New England, Myrexis Inc., Quest Clinical Research |
| NCT00967187 | Phase 2 | May 1, 2008 | Myrexis Inc. |
| NCT00511368 | Phase 2 | Apr 1, 2006 | Myrexis Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Myrexis Inc. | For profit | 4 | 4 | 1 | 2006 |
| AIDS Research Consortium of Atlanta | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Community Research Initiative of New England | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Quest Clinical Research | For profit | 1 | 0 | 1 | 2008 |
4 organizations
Page 1 / 1